Introduction. Gynaecological and reproductivehealth is an integral part of well-being in womenfrom menarche to menopause and monthly menstruation characterizes women’s life. In rheumaticdiseases (RDs), gynecological problems are oftenneglected even if they may therefore have a negative impact on quality of life.Aim: The aim of this study was to describe gynecological symptoms in premenopausal women withRDs and evaluate their impact on quality of life.Patients and Methods. A monocentric, cross-sectional observational study was conducted in theRheumatology Department of Careggi Hospital in Florence. Inclusion criteria were diagnosisof RDs, female gender, and premenopausal age.Gynecological anamnesis was obtained, symptoms were investigated, and all patients filled upa self-administered validated questionnaire. RDsgroup were also compared to a control group (HC)of 305 age matched health female.Results. From September 1st, 2020 to February 21 st, 2021, 200 patients were enrolled (meanage 39.1±8.7 years (M±SD)): 58% arthritis, 40%connective tissue disease and 1.5% systemicvasculitides. In family history, heavy menstrualbleeding (HMB), dysmenorrhea, or chronic pelvicpain were reported in 59%, 55 and 7% of patients,respectively. Mostly woman reported menstrualdisorders during adolescence (56% experienceddysmenorrhea and 52% HMB). Menstrual disorders and abnormal bleeding were frequentlyreported also in adulthood: 71% had dysmenorrhea and 47% reported HMB. Moreover, 26% ofpatients referred non- menstrual pelvic pain, 19%urinary pain and 18% pain during defecation. Vaginal symptoms were frequent: 36% of patientsreferred vaginal dryness, 29% burning, 19% recurrent vaginal infections and 39% dyspareunia.Uterine fibroma was present in 23% and endometriosis in 10% of patients. Comparing RDs to HC,menstrual disorders were significantly different inthe two groups. HMB was more frequent in the RDs group respect to the HC both during adolescence (55.6% and 25.4%, respectively; p=0.0001) and adult age (37.7% and 25.9%, respectively; p=0.0065). In adulthood, also dysmenorrhea was higher in Rs group respect to HC (51.7% and 45.4%, respectively; p=0.1971). RDs patients reported also dyspareunia with higher frequency than HC (17.9% and 8.1%; p=0.0022). Quality of life in RDs patients was lower than in HC women, in both physical and mental domains of SF-12: SF-physical was 41.5±12.4 and 51.2±6.0, respectively, p=0.0001; SF-mental was 44.7±11.2 and47.6±9.0, respectively, p=0.0014.Conclusions. Young premenopausal women with RDs frequently reported menstrual disorders(dysmenorrhea and HMB) that were significantly greater in RDs patients than in HC populationin both adolescence and adulthood and they may therefore have a negative impact on quality of life.For this reason, RDs patient should be always referred for an accurate evaluation of the gynaecological aspects (menstruation, fertility, maternity,bsexuality).

MENSTRUATION-RELATED DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS): BLEEDING AND PAIN / Orlandi, M.; Vannuccini, S.; EL AOUFY, K.; Melis, M.; BELLANDO RANDONE, S.; Guiducci, S.; MATUCCI CERINIC, M.; Petraglia, F.. - In: REUMATISMO. - ISSN 0048-7449. - (2021), pp. 183-183.

MENSTRUATION-RELATED DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS): BLEEDING AND PAIN

M. MATUCCI CERINIC
Penultimo
;
2021-01-01

Abstract

Introduction. Gynaecological and reproductivehealth is an integral part of well-being in womenfrom menarche to menopause and monthly menstruation characterizes women’s life. In rheumaticdiseases (RDs), gynecological problems are oftenneglected even if they may therefore have a negative impact on quality of life.Aim: The aim of this study was to describe gynecological symptoms in premenopausal women withRDs and evaluate their impact on quality of life.Patients and Methods. A monocentric, cross-sectional observational study was conducted in theRheumatology Department of Careggi Hospital in Florence. Inclusion criteria were diagnosisof RDs, female gender, and premenopausal age.Gynecological anamnesis was obtained, symptoms were investigated, and all patients filled upa self-administered validated questionnaire. RDsgroup were also compared to a control group (HC)of 305 age matched health female.Results. From September 1st, 2020 to February 21 st, 2021, 200 patients were enrolled (meanage 39.1±8.7 years (M±SD)): 58% arthritis, 40%connective tissue disease and 1.5% systemicvasculitides. In family history, heavy menstrualbleeding (HMB), dysmenorrhea, or chronic pelvicpain were reported in 59%, 55 and 7% of patients,respectively. Mostly woman reported menstrualdisorders during adolescence (56% experienceddysmenorrhea and 52% HMB). Menstrual disorders and abnormal bleeding were frequentlyreported also in adulthood: 71% had dysmenorrhea and 47% reported HMB. Moreover, 26% ofpatients referred non- menstrual pelvic pain, 19%urinary pain and 18% pain during defecation. Vaginal symptoms were frequent: 36% of patientsreferred vaginal dryness, 29% burning, 19% recurrent vaginal infections and 39% dyspareunia.Uterine fibroma was present in 23% and endometriosis in 10% of patients. Comparing RDs to HC,menstrual disorders were significantly different inthe two groups. HMB was more frequent in the RDs group respect to the HC both during adolescence (55.6% and 25.4%, respectively; p=0.0001) and adult age (37.7% and 25.9%, respectively; p=0.0065). In adulthood, also dysmenorrhea was higher in Rs group respect to HC (51.7% and 45.4%, respectively; p=0.1971). RDs patients reported also dyspareunia with higher frequency than HC (17.9% and 8.1%; p=0.0022). Quality of life in RDs patients was lower than in HC women, in both physical and mental domains of SF-12: SF-physical was 41.5±12.4 and 51.2±6.0, respectively, p=0.0001; SF-mental was 44.7±11.2 and47.6±9.0, respectively, p=0.0014.Conclusions. Young premenopausal women with RDs frequently reported menstrual disorders(dysmenorrhea and HMB) that were significantly greater in RDs patients than in HC populationin both adolescence and adulthood and they may therefore have a negative impact on quality of life.For this reason, RDs patient should be always referred for an accurate evaluation of the gynaecological aspects (menstruation, fertility, maternity,bsexuality).
2021
Disturbi mestruali
Dismenorrea
Endometriosi
File in questo prodotto:
File Dimensione Formato  
abstract SIR 2021-.pdf

solo gestori archivio

Licenza: Copyright dell'editore
Dimensione 272.01 kB
Formato Adobe PDF
272.01 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/154170
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact